1LLY:BIT
Eli Lilly And Co
€ 1,017.40
arrow_downward
-0.57%(-5.80) Siku 1
2 Okt, 17:29:23 GMT +2 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya 1LLY...
Fungua
€ 1,023.60
Juu
€ 1,031.00
Chini
€ 1,016.00
Mtaji wa soko
1.11T
Wastani wa kiasi cha mauzo
382.00
Kiasi cha mauzo ya hisa
492.00
Juu kwa wiki 52
€ 1,106.80
Chini kwa wiki 52
€ 640.70
Idadi ya wafanyakazi
elfu 50
Fungua
€ 1,023.60
Juu
€ 1,031.00
Chini
€ 1,016.00
Mtaji wa soko
1.11T
Wastani wa kiasi cha mauzo
382.00
Kiasi cha mauzo ya hisa
492.00
Juu kwa wiki 52
€ 1,106.80
Chini kwa wiki 52
€ 640.70
Idadi ya wafanyakazi
elfu 50
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Insider Monkey
·
saa 6 zilizopita
Eli Lilly (LLY) Posted 48% Revenue Growth. Why Does the Stock Trade Below Its Average Multiple?
AD HOC NEWS
·
saa 14 zilizopita
Eli Lilly stock enters weekly review with 21 dermatology presentations
Yahoo Finance
·
siku 1 iliyopita
Eli Lilly’s Biggest Shareholder Just Filed to Sell $347 Million of Stock
Investing.com
·
siku 1 iliyopita
Lilly presents exploratory biomarker data from psoriasis study
Wasifu
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Kuhusu Eli Lilly And Co
Afisa Mkuu Mtendaji (CEO)David A. Ricks
Wafanyakazielfu 50
Lilianzishwa1876
Makao makuuIndianapolis, Indiana, Marekani
Sekta-
Tovutililly.com